Shortly after Pfizer announced its intention to seek FDA authorization for a third COVID-19 vaccine shot on Thursday, the CDC, FDA and National Institutes of Health countered with a joint statement the same day saying, essentially, it’s still too soon.
In a battle of the booster shot statements, the vaccine manufacturer and the U.S. government are drawing very different conclusions based on the evidence to date.
Source: WebMD